Pfizer, Bristol-Myers Pill Eliquis Fails to Win FDA Approval

Pfizer, Bristol-Myers Pill Eliquis Fails to Win FDA Approval

Peter Foley/Bloomberg

A man walks past Pfizer Inc. headquarters in New York. Eliquis is one of three drugs Pfizer had been expecting to help replace revenue lost from Lipitor.